Outcomes of Adalimumab Therapy in Refractory Punctate Inner Choroidopathy and Multifocal Choroiditis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Outcomes of adalimumab therapy in refractory punctate inner choroidopathy and multifocal choroiditis
Graefes Arch. Clin. Exp. Ophthalmol 2022 Jun 01;260(6)2013-2021, O Shmueli, R AmerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.